Purification and characterization of a DNA-binding recombinant PREP1:PBX1 complex

PLoS One. 2015 Apr 9;10(4):e0125789. doi: 10.1371/journal.pone.0125789. eCollection 2015.

Abstract

Human PREP1 and PBX1 are homeodomain transcriptional factors, whose biochemical and structural characterization has not yet been fully described. Expression of full-length recombinant PREP1 (47.6 kDa) and PBX1 (46.6 kDa) in E. coli is difficult because of poor yield, high instability and insufficient purity, in particular for structural studies. We cloned the cDNA of both proteins into a dicistronic vector containing an N-terminal glutathione S-transferase (GST) tag and co-expressed and co-purified a stable PBX1:PREP1 complex. For structural studies, we produced two C-terminally truncated complexes that retain their ability to bind DNA and are more stable than the full-length proteins through various purification steps. Here we report the production of large amounts of soluble and pure recombinant human PBX1:PREP1 complex in an active form capable of binding DNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cloning, Molecular
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism
  • Electrophoretic Mobility Shift Assay
  • Genetic Vectors / genetics
  • Glutathione Transferase / genetics
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism*
  • Humans
  • Multiprotein Complexes / genetics
  • Multiprotein Complexes / metabolism*
  • Pre-B-Cell Leukemia Transcription Factor 1
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Recombinant Proteins / genetics*
  • Recombinant Proteins / metabolism

Substances

  • DNA-Binding Proteins
  • Homeodomain Proteins
  • Multiprotein Complexes
  • PKNOX1 protein, human
  • Pre-B-Cell Leukemia Transcription Factor 1
  • Proto-Oncogene Proteins
  • Recombinant Proteins
  • PBX1 protein, human
  • Glutathione Transferase

Grants and funding

AIRC/Marie Curie International Fellowship in Cancer Research funded C.B., and the European School of Molecular Medicine (SEMM) funded L.M. This work was supported by AIRC (Italian Association for Cancer Research) grant n. 12829 to F.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.